Henan Taloph Pharmaceutical Stock Co.,Ltd (SHA:600222)
China flag China · Delayed Price · Currency is CNY
7.18
-0.11 (-1.51%)
Apr 17, 2026, 3:00 PM CST

SHA:600222 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
65.8750.5343.56-72.26
Depreciation & Amortization
64.3764.4667.9362.9857.18
Other Amortization
8.768.867.774.953.31
Loss (Gain) From Sale of Assets
0.02-0.13-0.62-0.07-
Asset Writedown & Restructuring Costs
4.35-00.08-0.11.57
Loss (Gain) From Sale of Investments
0.15-10.676.4211.876.52
Provision & Write-off of Bad Debts
-7.0911.8633.8125.54
Other Operating Activities
81.2657.1647.2265.1791.74
Change in Accounts Receivable
-218.71-91.32-3.07-380.27-130.93
Change in Inventory
9.9491.06-7.38-70.61-37.3
Change in Accounts Payable
23.22-196.56-123.27231.5782.8
Operating Cash Flow
47.16-39.5943.74-124.4199.66
Operating Cash Flow Growth
----35.72%
Capital Expenditures
-21.12-37.23-43.13-66.62-39.07
Sale of Property, Plant & Equipment
0.070.170.220.190.06
Divestitures
0.09-1.80.20.57
Investment in Securities
-17.6749.44-164137.25-87.67
Other Investing Activities
38.85.8855.163.125.96
Investing Cash Flow
0.1618.25-150.02134.12-100.16
Long-Term Debt Issued
1,0391,3681,076950.091,298
Long-Term Debt Repaid
-1,240-1,264-938.41-1,403-1,381
Net Debt Issued (Repaid)
-201.52103.77137.3-452.6-82.27
Issuance of Common Stock
-0.0634.46137.1795.16
Repurchase of Common Stock
--21.28-42.07-37.66-45.48
Common Dividends Paid
-50.76-69.07-50.17-63.51-84.56
Other Financing Activities
236.92-23.26-52.97331.37-39.44
Financing Cash Flow
-15.37-9.7826.56-85.23-156.58
Net Cash Flow
31.95-31.11-79.72-75.51-157.08
Free Cash Flow
26.04-76.820.6-191.0360.58
Free Cash Flow Growth
----7717.75%
Free Cash Flow Margin
1.48%-3.96%0.03%-9.74%3.78%
Free Cash Flow Per Share
0.05-0.140.00-0.340.11
Cash Interest Paid
-1.60.83.734.54
Cash Income Tax Paid
70.6559.0384.459.5351
Levered Free Cash Flow
356.48-285.12-99.01361.28127.37
Unlevered Free Cash Flow
356.48-247.84-65.03401.67179.77
Change in Working Capital
-177.63-216.88-140.48-230.82-92.2
Source: S&P Global Market Intelligence. Standard template. Financial Sources.